| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 651.00M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BIO returned +23.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +23.4% |
| 1 year | +23.1% |
| 5 years | -53.5% |
| 10 years | +151.3% |
| All-time high | $804.82 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BIO would be worth today ›No. Bio-Rad Laboratories, Inc. has not paid a dividend in the past 12 months.
Bio-Rad Laboratories, Inc. stock trades on NYSE under the ticker symbol BIO.
Bio-Rad Laboratories, Inc. is part of the Healthcare sector.
Bio-Rad Laboratories, Inc. has a market cap of 10.00B USD, based on the latest quote.
Bio-Rad Laboratories, Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
